Pharmaceutical contract manufacturing companies play a crucial role in the healthcare sector, driving efficiency by producing drugs and medical products for other firms. These companies vary in size and expertise, from large corporates to niche biotech firms. They offer services such as product formulation, clinical trial support, and regulatory compliance, ensuring that medications meet strict quality standards. With the rise of personalized medicine and biopharmaceuticals, this industry is expanding rapidly, pushing for innovations in production techniques and sustainability practices, making it an essential component of modern healthcare solutions.

The following companies represent key players in pharmaceutical contract manufacturing. Ranging from 500 to over 12,000 employees, they are headquartered primarily in Europe and the United States. Established between 1946 and 2011, these firms specialize in varied services from drug substance development to complex biologics. Their impact on global markets is significant, servicing diverse clientele across multiple countries.

Read on to discover more about top pharmaceutical contract manufacturing companies.

Top 21 Pharmaceutical Contract Manufacturing Companies

1. Aenova Group

• Website: aenova-group.com
• Ownership type: Corporate
• Headquarters: Starnberg, Bavaria, Germany
• Employee distribution: Italy 46%, Germany 40%, Switzerland 7%, Other 7%
• Latest funding: April 2024
• Founded year: 2008
• Headcount: 1001-5000
• LinkedIn: aenova-group

Aenova Group, based in Starnberg, Bavaria, Germany, is a pharmaceutical manufacturer and contract development organization that specializes in providing a wide array of services in pharmaceutical manufacturing, development, and packaging. Founded in 2008, Aenova has grown to employ over 1,000 individuals and operates 14 production sites across Europe and the USA. The company serves both pharmaceutical and healthcare sectors, offering solutions for various dosage forms, including solids, semi-solids, liquids, and sterile products. Aenova is particularly noted for its capabilities in high-potent medicines and has established itself as a key player in the animal health market as well. Their facilities are equipped with modern technology and adhere to stringent quality standards, ensuring compliance with international regulations. Aenova's recent expansions, such as the addition of a gummy line and enhancements in development services, reflect their ongoing commitment to innovation and customer satisfaction.

2. Famar

• Website: famar-group.com
• Ownership type: Private Equity
• Headquarters: Athens, Central Athens Regional Unit, Greece
• Employee distribution: Greece 45%, Spain 30%, Italy 12%, Other 13%
• Latest funding: July 2024
• Founded year: 1949
• Headcount: 1001-5000
• LinkedIn: famar

Famar is a pharmaceutical manufacturer and contract development organization based in Athens, Greece. Founded in 1949, the company has developed a robust portfolio of services that cater to the needs of pharmaceutical companies. Famar specializes in research and development, manufacturing, quality assurance, regulatory compliance, and logistics. With a workforce of approximately 1,800 employees, the company operates six production sites and two R&D centers across Greece, Spain, and Italy. Famar is dedicated to maintaining high standards of quality and compliance, ensuring that its products meet the stringent requirements of the pharmaceutical industry. The company serves a wide array of clients, providing over 1,800 products in various dosage forms, and is active in more than 80 international markets. Famar's commitment to sustainability and operational excellence further underscores its role as a reliable partner in the pharmaceutical manufacturing sector.

3. Fareva

• Website: fareva.com
• Ownership type: Corporate
• Headquarters: Tournon-Sur-Rhône, Auvergne-Rhône-Alpes, France
• Employee distribution: France 47%, Brazil 21%, United States (USA) 12%, Other 20%
• Latest funding: September 2015
• Founded year: 1990
• Headcount: 10001+
• LinkedIn: fareva

Fareva, founded in 1990 and headquartered in Tournon-Sur-Rhône, France, operates as a pharmaceutical and contract manufacturing organization. The company specializes in the production of pharmaceuticals, active pharmaceutical ingredients (APIs), and cosmetic products. With a workforce of over 12,000 employees across 39 factories in 11 countries, Fareva serves clients in both the pharmaceutical and beauty industries. Their manufacturing capabilities include sterile and non-sterile products, with a focus on regulatory compliance and quality assurance. Fareva has made significant investments in its facilities, enhancing its ability to produce complex and highly potent compounds. Their recent collaboration with CureVac for the manufacturing of a COVID-19 vaccine candidate highlights their expertise and commitment to supporting innovative healthcare solutions.

4. Cambrex

• Website: cambrex.com
• Ownership type: Private Equity
• Headquarters: East Rutherford, New Jersey, United States (USA)
• Employee distribution: United States (USA) 73%, Italy 14%, Sweden 5%, Other 8%
• Latest funding: $2.0B, August 2019
• Founded year: 1981
• Headcount: 1001-5000
• LinkedIn: cambrex

Cambrex Corporation, founded in 1981 and based in East Rutherford, New Jersey, is a prominent player in the pharmaceutical contract manufacturing sector. As a Contract Development Manufacturing Organization (CDMO), Cambrex specializes in the development and manufacturing of drug substances and products, alongside providing analytical services. The company serves a wide array of pharmaceutical and biotechnology clients, offering comprehensive support throughout the drug lifecycle. Cambrex operates globally, with significant facilities in the United States, Italy, and Sweden, focusing on both custom and generic API manufacturing. Their extensive experience in generic API manufacturing, combined with a robust portfolio of analytical testing services, positions Cambrex as a key partner for companies looking to navigate the complexities of drug development and commercialization. In 2019, Cambrex secured a substantial funding amount, reflecting strong market confidence in their capabilities and future growth prospects.

5. FUJIFILM Diosynth Biotechnologies

• Website: fujifilmdiosynth.com
• Ownership type: Corporate
• Headquarters: Morrisville, North Carolina, United States (USA)
• Employee distribution: Denmark 43%, United States (USA) 40%, United Kingdom (UK) 17%
• Latest funding: $890.0M, August 2019
• Founded year: 2011
• Headcount: 1001-5000
• LinkedIn: fujifilm-diosynth-biotechnologies

FUJIFILM Diosynth Biotechnologies is a biotechnology company based in Morrisville, North Carolina, specializing in contract development and manufacturing services for biologics, vaccines, and advanced therapies. Founded in 2011, the company has quickly established itself as a key partner for pharmaceutical and biotechnology firms, providing expertise in cGMP processes to ensure the safe and effective delivery of products. With a workforce of over 5,000 employees distributed across facilities in the United States, Denmark, the United Kingdom, and Japan, FUJIFILM Diosynth Biotechnologies supports clients through all phases of drug development, from pre-clinical studies to commercialization. Their capabilities include mammalian cell culture, microbial fermentation, and advanced therapies such as gene and cell therapy. The company has made significant investments in expanding its manufacturing capacity, including a recent $890 million funding round aimed at enhancing its large-scale cell culture operations. This strategic focus on innovation and quality positions FUJIFILM Diosynth Biotechnologies as a vital player in the pharmaceutical contract manufacturing sector.

6. NextPharma

• Website: nextpharma.com
• Ownership type: Private Equity
• Headquarters: London, England, United Kingdom (UK)
• Employee distribution: France 36%, Germany 31%, Norway 11%, Other 22%
• Latest funding: June 2017
• Founded year: 1946
• Headcount: 1001-5000
• LinkedIn: nextpharma

NextPharma is a pharmaceutical contract development and manufacturing organization based in London, UK. Founded in 1946, the company has established itself as a reliable partner for pharmaceutical clients by providing a full range of services that support drug development and manufacturing needs. Their offerings include pharmaceutical development, clinical trials supply services, commercial manufacturing, and packaging. With a workforce of over 2,000 employees, NextPharma operates across several European countries, including Germany, France, and Norway, ensuring a broad reach in the market. The company is committed to maintaining high-quality standards, as evidenced by successful audits from regulatory bodies such as the FDA and EMA. Additionally, NextPharma is focused on sustainability, aiming to achieve carbon neutrality by 2025, which aligns with the growing emphasis on environmental responsibility in the pharmaceutical industry.

7. Ajinomoto Bio-Pharma Services

• Website: ajibio-pharma.com
• Ownership type: Private
• Headquarters: San Diego, California, United States (USA)
• Employee distribution: United States (USA) 49%, Belgium 32%, India 19%
• Founded year: 1998
• Headcount: 1001-5000
• LinkedIn: ajibio-pharma-services

Ajinomoto Bio-Pharma Services, founded in 1998 and based in San Diego, California, is a pharmaceutical manufacturer that specializes in contract development and manufacturing organization (CDMO) services. The company offers a comprehensive suite of services that includes small and large molecule manufacturing, drug product manufacturing, and development services tailored for biotechnology and pharmaceutical companies. Ajinomoto Bio-Pharma emphasizes quality and compliance, ensuring that their clients can efficiently bring therapeutic products to market. With facilities in the United States, Belgium, and India, they leverage a global workforce to support their operations. Their expertise spans various areas, including highly potent drug manufacturing and antibody-drug conjugates, showcasing their capability to handle complex pharmaceutical needs. The company has not reported any recent funding, indicating a stable operational model without reliance on external financial support.

8. Medreich Limited

• Website: medreich.com
• Ownership type: Corporate
• Headquarters: Feltham, England, United Kingdom (UK)
• Employee distribution: India 98%, Other 2%
• Latest funding: $290.0M, June 2014
• Founded year: 1976
• Headcount: 1001-5000
• LinkedIn: medreich-limited

Medreich Limited is a pharmaceutical manufacturer based in Feltham, England, with a strong emphasis on contract manufacturing and development services for pharmaceutical preparations. Founded in 1976, the company has built a reputation for providing high-quality services to multinational corporations in the pharmaceutical industry. Medreich specializes in various aspects of pharmaceutical manufacturing, including formulation development, clinical manufacturing, and regulatory support. With a workforce of approximately 1,735 employees, the company operates globally, serving clients across more than 60 countries. Medreich is part of the Meiji Group, a Japanese conglomerate, which further strengthens its capabilities and market reach. The company is dedicated to delivering innovative solutions and quality medicines, ensuring compliance with stringent regulatory standards. Medreich's advanced research and development center is equipped to develop patent non-infringing and niche generics, catering to regulated markets worldwide.

9. Hovione

• Website: hovione.com
• Ownership type: Family Owned
• Headquarters: East Windsor, New Jersey, United States (USA)
• Employee distribution: Portugal 79%, Ireland 9%, United States (USA) 9%, Other 3%
• Founded year: 1959
• Headcount: 1001-5000
• LinkedIn: hovione

Hovione is a family-owned Contract Development and Manufacturing Organization (CDMO) based in East Windsor, New Jersey, with a rich history dating back to 1959. The company specializes in providing comprehensive services to the pharmaceutical industry, including drug substance and product manufacturing, particle engineering, and analytical support. Hovione caters to pharmaceutical companies that require high-quality solutions to bring both new and off-patent drugs to market. With a workforce of over 2,100 employees, Hovione operates manufacturing sites across several countries, including Portugal, Ireland, and the United States. Their commitment to quality is reflected in their rigorous adherence to regulatory standards, ensuring that they meet the highest expectations of their clients. Hovione's innovative approaches, such as their spray drying technology, address complex challenges in drug formulation, further solidifying their role in the pharmaceutical sector.

10. Pii, A Jabil Company

• Website: pharm-int.com
• Ownership type: Corporate
• Headquarters: Cockeysville, Maryland, United States (USA)
• Employee distribution: United States (USA) 99%
• Latest funding: February 2025
• Founded year: 1994
• Headcount: 201-500
• LinkedIn: pharmaceutics-international

Pii, A Jabil Company, also known as Pharmaceutics International, Inc., is a contract development and manufacturing organization (CDMO) based in Cockeysville, Maryland. Established in 1994, Pii has grown to employ around 362 professionals, including a significant number of scientists and support staff. The company operates a state-of-the-art facility that spans over 360,000 square feet, featuring more than 70 manufacturing rooms designed for various pharmaceutical applications. Pii specializes in providing tailored solutions for drug development, focusing on formulation and process development, analytical services, and quality assurance. Their expertise includes handling high-potency active pharmaceutical ingredients (HPAPIs) and offering aseptic fill-finish services for injectables. Pii's commitment to quality is evident in their adherence to current Good Manufacturing Practices (cGMP) and their proactive approach to regulatory compliance. They work closely with clients to navigate the complexities of drug development, ensuring efficient and effective pathways from concept to commercialization.

11. Bushu Pharmaceuticals Ltd.

• Website: bushu-pharma.com
• Ownership type: Private Equity
• Headquarters: Kawagoe, Saitama, Japan
• Employee distribution: Japan 100%
• Latest funding: $769.0M, December 2022
• Founded year: 1998
• Headcount: 1001-5000
• LinkedIn: bushu-pharmaceuticals-ltd-

Bushu Pharmaceuticals Ltd., founded in 1998 and based in Kawagoe, Saitama, Japan, is a pharmaceutical manufacturer that specializes in contract manufacturing of pharmaceuticals and clinical trial drugs. The company offers a range of services, including the production of solid dosage forms, injectable packaging, and comprehensive quality control. They primarily serve pharmaceutical companies and healthcare providers, ensuring that their products meet stringent global regulatory standards. With a workforce of approximately 1,600 employees, Bushu operates five manufacturing facilities, which are equipped to handle various pharmaceutical production needs. The company has achieved GMP certification from major regulatory bodies, allowing them to export products to 56 countries. Their recent funding of 769 million yen in December 2022 reflects their commitment to enhancing their manufacturing capabilities and expanding their market reach. Bushu Pharmaceuticals is also actively engaged in sustainability initiatives, aligning their operations with the principles of social responsibility and environmental stewardship.

12. Rottendorf Pharma

• Website: rottendorf.com
• Ownership type: Private
• Headquarters: Ennigerloh, North Rhine-Westphalia, Germany
• Employee distribution: Germany 96%, France 3%
• Founded year: 1928
• Headcount: 1001-5000
• LinkedIn: rottendorfpharma

Rottendorf Pharma GmbH, based in Ennigerloh, North Rhine-Westphalia, Germany, is a contract development and manufacturing organization (CDMO) that has been active since 1928. The company specializes in oral solid dosage forms, providing a range of services that include development, manufacturing, packaging, and analytics. Rottendorf Pharma operates as an extension of its clients' operations, focusing on building sustainable partnerships with pharmaceutical companies worldwide. The firm prides itself on its Total Process Ownership (TPO©), Total Technology Mastering (TTM), and Total Supply Integrity (TSI) concepts, which enhance operational efficiency and product quality. Rottendorf Pharma does not market its own products, ensuring that it does not compete with its clients. The company has a strong commitment to quality assurance, evidenced by its extensive history of regulatory inspections by authorities such as the EMA and FDA. With a workforce of around 344 employees, Rottendorf Pharma is recognized as one of the top employers in the Münsterland region, reflecting its dedication to employee welfare and corporate responsibility.

13. OLIC (Thailand) Ltd.

• Website: olic-thailand.com
• Ownership type: Corporate
• Headquarters: Thailand
• Employee distribution: Thailand 100%
• Latest funding: May 2020
• Founded year: 1984
• Headcount: 501-1000
• LinkedIn: olic-thailand-ltd

OLIC (Thailand) Ltd. is a pharmaceutical manufacturer based in Thailand, specializing in contract manufacturing and development services for healthcare products. Founded in 1984, the company has grown to serve over 30 multinational pharmaceutical clients, ensuring high-quality production that meets stringent regulatory standards. OLIC operates primarily in the pharmaceutical and healthcare sectors, contributing to advancements in healthcare through innovative services. The company has received multiple accolades, including the Thai FDA Quality Award for 2021 and 2022, highlighting its commitment to quality and compliance. OLIC's manufacturing facility adheres to GMP requirements and is capable of managing the entire regulatory approval process for products intended for both local and international markets. As a member of the Fuji Pharma Group since 2012, OLIC has strengthened its manufacturing capabilities and is expanding its business scope in the APAC region, aiming to market its own pharmaceutical products alongside its contract manufacturing services.

14. IDT Biologika

• Website: idt-biologika.com
• Ownership type: Corporate
• Headquarters: Dessau-Roßlau, Saxony-Anhalt, Germany
• Employee distribution: Germany 87%, United States (USA) 12%
• Latest funding: $243.8M, June 2024
• Founded year: 1921
• Headcount: 1001-5000
• LinkedIn: idt-biologika-gmbh

IDT Biologika, founded in 1921 and headquartered in Dessau-Roßlau, Germany, is a contract development and manufacturing organization (CDMO) that specializes in the biopharmaceutical industry. The company provides comprehensive services in the development and manufacturing of vaccines, cell and gene therapies, and other biologics. With a workforce of around 1,700 employees, IDT Biologika operates facilities in Europe and North America, allowing them to support pharmaceutical and biotech companies in bringing their therapeutic products to market. Their expertise includes drug substance manufacturing, aseptic fill-finish, and regulatory support, making them a valuable partner for clients navigating complex compliance landscapes. IDT Biologika has invested over €600 million since 1993, with a significant portion allocated in recent years to enhance their capabilities. Their strong regulatory track record and commitment to quality have earned them approvals from major health authorities, including the EMA and FDA.

15. Rentschler Biopharma

• Website: rentschler-biopharma.com
• Ownership type: Venture Capital
• Headquarters: Laupheim, Baden-Württemberg, Germany
• Employee distribution: Germany 64%, United States (USA) 31%, United Kingdom (UK) 5%
• Latest funding: Series A, $1.6M, May 2016
• Founded year: 1927
• Headcount: 1001-5000
• LinkedIn: rentschler-biopharma-se

Rentschler Biopharma SE, founded in 1927 and based in Laupheim, Germany, is a biopharmaceutical contract manufacturer that provides a wide range of services tailored to the needs of biopharmaceutical firms. The company focuses on biopharmaceutical development, cGMP manufacturing, and regulatory consulting, catering to clients who require specialized knowledge in producing complex biological products. With a workforce of approximately 1,400 employees across its facilities in Germany, the United States, and the United Kingdom, Rentschler Biopharma has built a robust operational framework. The company has been involved in the production of therapeutic proteins and advanced therapies, showcasing its capability to handle intricate manufacturing processes. Rentschler Biopharma has also received funding, with a notable Series A round in 2016, which supports its ongoing growth and innovation in the biopharmaceutical sector.

16. Doppel Farmaceutici

• Website: doppel.it
• Ownership type: Private Equity
• Headquarters: Cortemaggiore, Emilia-Romagna, Italy
• Employee distribution: Italy 100%
• Latest funding: July 2015
• Founded year: 1994
• Headcount: 501-1000
• LinkedIn: doppel-farmaceutici-srl

Doppel Farmaceutici, founded in 1994, is a contract development and manufacturing organization based in Cortemaggiore, Italy. The company specializes in producing pharmaceutical and nutritional products, offering a comprehensive range of services that include finished dosage forms manufacturing and research and development. With a workforce of approximately 580 employees, Doppel operates two advanced manufacturing facilities located in Cortemaggiore and Rozzano. These facilities are equipped to handle a variety of dosage forms, including solid, liquid, and semi-solid products. The company has established partnerships with over 70 clients in the pharmaceutical sector, providing tailored solutions to meet specific needs. Doppel is committed to maintaining high-quality standards and has received various certifications from international regulatory bodies. In 2024, Doppel announced a merger with Mipharm, creating a new entity named DMX Pharma, which aims to enhance their capabilities and market reach in the pharmaceutical contract manufacturing industry.

17. Avara Pharmaceutical Services

• Website: avara.com
• Ownership type: Private
• Headquarters: Norman, Oklahoma, United States (USA)
• Employee distribution: Italy 38%, United States (USA) 25%, Puerto Rico 23%, Other 14%
• Founded year: 2016
• Headcount: 501-1000
• LinkedIn: avara-pharmaceutical-services

Avara Pharmaceutical Services, Inc. is a private pharmaceutical contract manufacturer based in Norman, Oklahoma, with additional facilities in Arecibo, Puerto Rico, and Liscate, Italy. Established in 2016, Avara specializes in providing tailored outsourcing services to pharmaceutical innovators and drug developers. The company focuses on sterile fill-finish, oral solid dosage manufacturing, and integrated packaging, supporting clients in efficiently bringing quality products to market. Avara's operations are characterized by a commitment to collaboration and flexibility, ensuring that they meet the specific needs of their clients. With a workforce of approximately 531 employees, Avara has built a reputation for responsiveness and quality, leveraging decades of experience in large-scale commercial supply within the pharmaceutical industry. Their facilities are equipped to handle a range of products, including potent compounds, and they maintain a strong regulatory compliance record with approvals from agencies such as the FDA and EMA. Avara's mission is to redefine the relationship between contract service providers and pharmaceutical companies, aiming for a truly collaborative partnership that enhances the drug development process.

18. DPT Laboratories

• Website: dptlabs.com
• Ownership type: Private Equity
• Headquarters: San Antonio, Texas, United States (USA)
• Employee distribution: United States (USA) 99%, Other 1%
• Latest funding: January 2025
• Founded year: 1938
• Headcount: 501-1000
• LinkedIn: dpt-laboratories

DPT Laboratories, founded in 1938 and based in San Antonio, Texas, is a contract development and manufacturing organization (CDMO) that specializes in pharmaceutical services. The company offers a comprehensive suite of solutions, including drug formulation, stability testing, and clinical trial supplies. DPT primarily serves pharmaceutical companies and contract research organizations (CROs), helping them navigate the complex journey from product development to commercial manufacturing. With a workforce of approximately 478 employees, DPT has built a reputation for its expertise in semi-solid and liquid dosage forms, including aerosols, creams, gels, and ointments. Their commitment to quality and customer support is evident in their approach to scaling up from research and development to full-scale commercialization. DPT's long-standing presence in the industry and its focus on continuous improvement make it a relevant player in the pharmaceutical contract manufacturing sector.

19. Carbogen Amcis

• Website: carbogen-amcis.com
• Ownership type: Corporate
• Headquarters: Bubendorf, Basel, Switzerland
• Employee distribution: Switzerland 56%, France 19%, Netherlands 11%, Other 14%
• Latest funding: $75.0M, August 2006
• Founded year: 1982
• Headcount: 1001-5000
• LinkedIn: carbogen-amcis

Carbogen Amcis, based in Bubendorf, Switzerland, is a pharmaceutical manufacturer with a focus on drug substance and drug product development. Founded in 1982, the company has built a reputation for providing comprehensive services to pharmaceutical and biopharmaceutical clients. Their offerings include active pharmaceutical ingredient (API) manufacturing, regulatory support, and specialty manufacturing. With a workforce of over 700 employees and a presence in multiple countries, including France, the Netherlands, the UK, and China, Carbogen Amcis supports clients through the complexities of drug development and market launch. The company has demonstrated its capabilities through successful FDA inspections and has been recognized for its manufacturing performance in the industry. Their expertise extends to highly potent APIs and specialized products, such as cholesterol and vitamin D analogs, showcasing their ability to meet various client needs in the pharmaceutical sector.

20. KLEVA Pharmaceuticals S.A.

• Website: kleva.gr
• Ownership type: Private
• Headquarters: Athens, Central Athens Regional Unit, Greece
• Employee distribution: Greece 98%, Iraq 2%
• Founded year: 1974
• Headcount: 201-500
• LinkedIn: kleva-pharmaceuticals-s-a-

KLEVA Pharmaceuticals S.A. is a private pharmaceutical manufacturer based in Athens, Greece, founded in 1974. The company specializes in product development and contract manufacturing services, catering to pharmaceutical businesses by providing high-quality manufacturing of medications, food supplements, and health products. KLEVA is dedicated to ensuring compliance with stringent regulatory standards, which is crucial in the pharmaceutical industry. With a workforce of approximately 129 employees, KLEVA has expanded its operations globally since 1999, serving over 50 customers in more than 30 countries. Their service offerings include research and development, quality assurance, and technology transfer, making them a comprehensive partner for pharmaceutical companies. KLEVA's production facilities adhere to European standards, ensuring that their products meet the necessary quality and safety requirements. The company has also invested in expanding its capabilities, including the installation of a filling machine for sterile products and the establishment of a dedicated tech transfer department. This commitment to growth and quality positions KLEVA as a significant player in the pharmaceutical contract manufacturing sector.

21. Cenexi

• Website: cenexi.com
• Ownership type: Corporate
• Headquarters: Fontenay-Sous-Bois, Île-De-France, France
• Employee distribution: France 68%, Belgium 32%
• Latest funding: $123.9M, November 2022
• Founded year: 2004
• Headcount: 1001-5000
• LinkedIn: cenexi

Cenexi, founded in 2004 and based in Fontenay-Sous-Bois, Île-De-France, France, is a corporate entity with a workforce of over 1,000 employees. The company operates as a Contract Development and Manufacturing Organization (CDMO), focusing on the production of both sterile and non-sterile pharmaceutical products. Cenexi provides a wide range of services, including pharmaceutical development, analytical services, and regulatory support, catering to the needs of pharmaceutical laboratories and biotech firms. Their expertise extends to the manufacturing of complex products, including hormones and biologics, and they have made significant investments in their facilities to enhance production capabilities. Cenexi's commitment to quality and innovation is evident in their operations, which are designed to meet stringent regulatory standards across various markets. The company has also received substantial funding, amounting to approximately 123 million euros in November 2022, which underscores their growth ambitions and strategic importance in the pharmaceutical sector.

Pharmaceutical Contract Manufacturing Insights: Key Companies

Want to Find More Pharmaceutical Contract Manufacturing Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!